» Authors » H Gatica

H Gatica

Explore the profile of H Gatica including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 107
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cuchacovich M, Catalan D, Wainstein E, Gatica H, Soto L, Aravena O, et al.
Clin Exp Rheumatol . 2009 Feb; 26(6):1067-73. PMID: 19210871
Objective: To investigate the effect of adalimumab treatment on anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis (RA). Methods: 70 RA patients who failed treatment with disease modifying...
2.
Araya A, Rojas P, Fritsch R, Rojas R, Herrera L, Rojas G, et al.
Endocrine . 2007 May; 30(3):289-98. PMID: 17526941
A link between stressful life events and development or exacerbation of depression has been established via a large body of evidence. An alteration in the regulation of the hypothalamic-pituitary-adrenal (HPA)...
3.
Cuchacovich M, Soto L, Edwardes M, Gutierrez M, Llanos C, Pacheco D, et al.
Scand J Rheumatol . 2007 Mar; 35(6):435-40. PMID: 17343250
Objective: To investigate the influence of -308 tumour necrosis factor-alpha (TNFalpha) promoter polymorphism and circulating TNFalpha levels in the clinical response to adalimumab treatment in patients with rheumatoid arthritis (RA)....
4.
Cuchacovich M, Merino G, Yamamoto J, Villarroel F, Saavedra T, Jofre S, et al.
Clin Exp Rheumatol . 2005 Nov; 23(4 Suppl 38):S27-34. PMID: 16273761
Objectives: Lipoteichoic acid (LTA), induces some of the clinical symptoms of Behçet's disease (BD) in a rat animal model. These results led to the hypothesis that LTA may also trigger...
5.
Cuchacovich M, Ferreira L, Aliste M, Soto L, Cuenca J, Cruzat A, et al.
Scand J Rheumatol . 2004 Sep; 33(4):228-32. PMID: 15370717
Objective: To investigate the influence of -308 tumour necrosis factor-alpha (TNF-alpha) promoter polymorphism and circulating TNF-alpha levels in the clinical response to the infliximab treatment in patients with rheumatoid arthritis...
6.
Cuchacovich M, Gatica H, Pizzo S, Gonzalez-Gronow M
Clin Exp Rheumatol . 2002 Jan; 19(6):673-80. PMID: 11791639
Objectives: To assess the serum levels, specific activity and other characteristics of dipeptidylpeptidase IV (DPP IV/CD26), an ectoenzyme that plays a critical role in the modulation and expression of autoimmune...
7.
Cuchacovich T M, Pacheco P, Merino G, Gallardo P, Gatica H, Valenzuela H, et al.
Rev Med Chil . 2001 May; 128(11):1205-14. PMID: 11347507
Background: Scleritis and episcleritis may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. Aim: To evaluate the ocular complications and systemic...
8.
Cuchacovich M, Gatica H, Munoz S, Gonzalez P
Rev Med Chil . 2000 Aug; 128(3):301-8. PMID: 10962872
Background: No reliable variables to predict clinical or laboratory response to treatment in patients with rheumatoid arthritis were available until recently. Aim: To asses the potential predictive value of the...
9.
Cuchacovich M, Holuigue G, Gatica H, Alvo M, Murray G
Rev Med Chil . 2000 Jul; 128(1):86-92. PMID: 10883527
Although fibrosis and vasculopathy coexist in most patients with progressive systemic sclerosis, it is not clear if these events are the result of an unique etiologic factor or if one...
10.
Cuchacovich M, Gatica H, Verdaguer J, Carreno M, Villarroel F, Verdaguer J
Rev Med Chil . 1999 Aug; 127(3):277-85. PMID: 10436711
Background: Cyclosporin A has an adequate immunosuppressive capacity and can be useful in the treatment of non infectious ocular inflammatory diseases. Aim: To describe the clinical effect of cyclosporin A...